Pleomorphic Xanthoastrocytoma Completed Phase 2 Trials for Dabrafenib (DB08912)

Also known as: Pleomorphic Xanthoastrocytoma of Brain / Pleomorphic Xantho-Astrocytoma / Pleomorphic Xanthoastrocytomas / Pleomorphic xanthoastrocytoma (morphologic abnormality) / Pleomorphic xanthoastrocytoma of brain (disorder) / Astrocytoma, Grade II / Diffuse astrocytoma (morphologic abnormality) / Astrocytoma low grade (morphologic abnormality) / Astrocytoma, low grade

DBCOND0062672 (Pleomorphic Xanthoastrocytoma)Completed2 IdentifierTitlePurposeDrugs
NCT02684058Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG TumorsTreatment